Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-04

FDA Approved: SELZENTRY — Original Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approves SELZENTRY (maraviroc) under the original application for treatment of HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Selzentry (Maraviroc)

Snippet

ORIG AP for SELZENTRY (MARAVIROC)